A biomarker is a quality that can be examined as a marker of pathogenic and organic procedure alongside pharmacological reaction to a remedial inclusion. They demonstrate either ordinary or sick capacity in the body. Biomarkers are specific particles, qualities, quality items, hormones, cells or chemicals. Tumour markers are created from ordinary cells and malignancy cells. Most tumour markers are proteins. In addition, as of late, plans of quality articulation and change to DNA have additionally started to be utilized as tumour markers.
Related: Molecular Biology Conferences | Molecular Biology Meetings | Molecular Biology Congress |Molecular Biology Summits | Molecular Biology Events | Genetic Engineering Congress | Genetic Engineering Conferences | Genetic Engineering Summit
Related Conferences: 13th World Cancer Congress on February 25-27, 2019 at Paris, France International Conference on Biomarkers on March 11-12, 2019 at London, UK; 6th International Conference on Lung Cancer and COPD on June 17-18, 2019 at Dublin, Ireland; 15th Global Biomarkers Summit on March 20-21, 2019 at Paris, France; 9th Annual Conference on Clinical Research & Biomarkers on March 07-08, 2019 at Amsterdam, Netherlands
Recommended Association & Societies: Association of Cardiovascular Biomarker | American Federation for Medical Research (AFMR) | The European Association of Nuclear Medicine (EANM) | Chinese Society for Cell Biology (CSCB) | The Association for Molecular Pathology (AMP) | Molecular Pathology Association of India (MPAI)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
